Black Diamond Therapeutics, Inc.
BDTX • NASDAQ • Stock Fundamentals
Black Diamond Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mark A. Velleca, with a market cap of $104.3M.
Market Cap$104.3M
Employees54.0
CEOMark A. Velleca
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Black Diamond Therapeutics, Inc. FAQ
Common questions about Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. (BDTX) has a market capitalization of $104.3M and trades on NASDAQ.
Black Diamond Therapeutics, Inc. has approximately 54 employees.